Sutureless Aortic Valve Replacement in a Patient with Transfemoral Aortic Valve Replacement and Left Ventricular Hypertrophy

Abstract

Background Transarterial valve intervention (TAVI) is valuable in high-risk patients, however, in case of left ventricular outflow tract (LVOT) obstruction, conventional surgery, including partial myectomy, is indicated.

Case Description An 84-year-old female patient presented with increasing fatigue after TAVI in 2012, demonstrated a narrowed LVOT. Conventional surgery was performed, including removal of the transcathether valve, partial septal myectomy, and implantation of a sutureless valve. The postoperative course was uncomplicated.

Conclusion Aortic valve stenosis combined with severe left-ventricular hypertrophy is not ideal for TAVI. Conventional surgery, performing partial septal myectomy and implantation of sutureless aortic prosthesis, seems more appropriate.

Keywords

aortic valve - heart valve - TAVI - cardiomyopathy - sutureless aortic valve

• References

• 1 Svensson LG, Blackstone EH, Rajeswaran J , et al; PARTNER Trial Investigators. Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial. J Am Coll Cardiol 2014; 64 (2) 158-168
• 2 Gersh BJ, Maron BJ, Bonow RO , et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2011; 142 (6) e153-e203
• 3 Spethmann S, Dreger H, Baldenhofer G , et al. Long-term Doppler hemodynamics and effective orifice areas of Edwards SAPIEN and medtronic CoreValve prostheses after TAVI. Echocardiography 2014; 31 (3) 302-310
• 4 Sakamoto Y, Hashimoto K, Okuyama H, Ishii S, Shingo T, Kagawa H. Prevalence of pannus formation after aortic valve replacement: clinical aspects and surgical management. J Artif Organs 2006; 9 (3) 199-202
• 5 Borger MA, Moustafine V, Conradi L , et al. A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. Ann Thorac Surg 2015; 99 (1) 17-25
• 6 Rubino AS, Santarpino G, De Praetere H , et al. Early and intermediate outcome after aortic valve replacement with a sutureless bioprosthesis: Results of a multicenter study. J Thorac Cardiovasc Surg 2014; 148 (3) 865-871 , discussion 871
• 7 Borger MA, Dohmen P, Misfeld M, Mohr FW. Current trends in aortic valve replacement: development of the rapid deployment EDWARDS INTUITY valve system. Expert Rev Med Devices 2013; 10 (4) 461-470